Legend Biotech (LEGN) Other Operating Expenses (2020 - 2025)

Legend Biotech (LEGN) has 5 years of Other Operating Expenses data on file, last reported at -$5.1 million in Q1 2026.

• Quarterly Other Operating Expenses rose 90.64% year-over-year to -$5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.1 million (up 90.64% YoY) and the FY2024 annual result came in at -$4423.0, changed N/A from the prior year.
• Other Operating Expenses advanced to -$5.1 million in Q1 2026, from -$54.5 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of -$4423.0 in Q4 2024 to a low of -$54.5 million in Q1 2025.
• A 3-year average of -$19.9 million and a median of -$5.1 million in 2026 frame the typical range for Other Operating Expenses.
• The widest YoY moves for Other Operating Expenses: up 90.64% in 2026, down 90.64% in 2026.
• Tracing LEGN's Other Operating Expenses over 3 years: stood at -$4423.0 in 2024, then slumped by 1232095.34% to -$54.5 million in 2025, then soared by 90.64% to -$5.1 million in 2026.
• The last three Other Operating Expenses figures came in at -$5.1 million (Q1 2026), -$54.5 million (Q1 2025), and -$4423.0 (Q4 2024), per Business Quant data.